Skip to main content
Fig. 2 | Applied Cancer Research

Fig. 2

From: Biomarker testing for advanced lung cancer by next-generation sequencing; a valid method to achieve a comprehensive glimpse at mutational landscape

Fig. 2

Lollipop plots depicting the distribution of (A) TP53 (B) EGFR (C) KRAS mutations detected on NGS in the study group (N = 100, carcinoma lung subjects). Please note: The four uncommon EGFR gene mutations (p.D770delinsES, p.D770_771insG, p.A767_S768insSVD, p.P772_H773insHV) have been depicted as ‘U’ in the panel B. (GenBank Reference TP53: NM_000546, EGFR: NM_005228, KRAS: NM_033360)

Back to article page

Applied Cancer Research

ISSN: 1980-5578